An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)
NCT00109148 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2015-09-09
Summary
The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with obesity (considerably overweight).
Conditions
Interventions
- DRUG
-
MK0364
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Monitor · Merck Sharp & Dohme LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-07-31
- Primary Completion
- 2005-01-31
- Completion
- 2005-02-28
More Related Trials
-
Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
NCT03661879 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)
NCT00533598 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)
NCT00533481 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MK0364 in Obese Patients (0364-014)
NCT00131391 ·Status: TERMINATED ·Phase: PHASE3
-
A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity
NCT03479892 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity
NCT06577766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin
NCT06064006 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
NCT07184632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
NCT04010786 ·Status: COMPLETED ·Phase: PHASE1
-
Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity
NCT03308721 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of HS-20094 in Chinese Adults with Overweight or Obesity
NCT06839664 ·Status: RECRUITING ·Phase: PHASE3
-
Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects
NCT00909766 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity
NCT06478563 ·Status: COMPLETED ·Phase: PHASE1
-
Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)
NCT05035095 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-5823 in Overweight or Obese Participants Who Are Healthy or Have Type 2 Diabetes Mellitus (MK-5823-002)
NCT01614782 ·Status: TERMINATED ·Phase: PHASE1
-
A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity
NCT02835235 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers
NCT00959426 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
NCT06859268 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus
NCT05814107 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.
NCT00396448 ·Status: TERMINATED ·Phase: PHASE3
-
A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity
NCT06737536 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of TG103 Injection in Overweight or Obesity
NCT05299697 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects
NCT06054698 ·Status: COMPLETED ·Phase: PHASE2
-
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
NCT05891834 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Safety, Tolerability, and Pharmacokinetics of MEDI0382 in Non-diabetic Obese Participants
NCT03625778 ·Status: COMPLETED ·Phase: PHASE1